Eisai Co., Ltd. is a global pharmaceutical company based in Japan. It specializes in the research, development, and marketing of prescription drugs, focusing on neurology and oncology.
The company provides solutions in the fields of oncology, neurology, and other therapeutic areas, with a strong focus on research and development.
Eisai prioritizes sustainable practices in healthcare, environmental management, and social responsibility through green chemistry and energy-saving initiatives.
Eisai has a significant global presence in over 70 countries with manufacturing facilities and research centers worldwide.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| Eisai Co., Ltd. | https://www.eisai.com/ |
| Company Name | Eisai Co., Ltd. |
| Core Focus | Research, development, manufacturing, and commercialization of innovative pharmaceutical products |
| Sustainability Recognition | Commitment to improving health and sustainability through innovation |
| Key Technologies | Drug discovery, cancer immunotherapy, enzyme inhibitors |
| Industry | Pharmaceutical |
| Solutions Offered | Pharmaceuticals for neurological and oncology treatments, healthcare solutions |
| Application Areas | Neurology, oncology, gastrointestinal diseases |
FAQs
Eisai Co., Ltd. primarily focuses on neurological diseases and cancers.
The company's key products include treatments for epilepsy, Alzheimer's disease, and cancer therapies.
Eisai Co., Ltd. contributes to sustainability through eco-friendly production processes and improving access to medicine.
Eisai Co., Ltd. is headquartered in Tokyo, Japan.
Yes, Eisai Co., Ltd. offers innovative therapies for oncology, including cancer immunotherapies.